Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 4Brain Neoplasms 4Pancreatic Neoplasms 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Lung Neoplasms 2Glioma 2Esophageal Neoplasms 2Craniopharyngioma 2Wilms Tumor 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Resectable Lung Non-Small Cell Carcinoma 1Recurrent Head and Neck Carcinoma 1Radiation Injuries 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Meningioma 1Gliosarcoma 1Eye Neoplasms 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Chordoma 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Fluorouracil 13Cisplatin 7Radiotherapy 6Specimen Handling 5Mitomycin 5Capecitabine 5pembrolizumab 4dehydroftorafur 4Radiation 4Drug Therapy 4Cetuximab 4Radiotherapy, Intensity-Modulated 3Paclitaxel 3Nivolumab 3Magnetic Resonance Spectroscopy 3Carboplatin 3Biopsy 3tislelizumab 2durvalumab 2aldesleukin 2VGX-3100 2Platinum 2Mitozytrex 2Immune Checkpoint Inhibitors 2Fluorodeoxyglucose F18 21,2-diaminocyclohexaneplatinum II citrate 2toripalimab 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1spartalizumab 1rocakinogene sifuplasmid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anus Neoplasms × Proton Therapy × Clear all
NCT03018418 2024-09-19

Proton Therapy in Reducing Toxicity in Anal Cancer

University of Cincinnati

Phase 2 Active not recruiting
14 enrolled 14 charts
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡